Pathobiologic markers of the Ewing sarcoma family of tumors: State of the art and prediction of behaviour

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Pinto, Alfredo ^a   Dickman, Paul ^b,c   Parham, David ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CD133 ANTIGEN; CD57 ANTIGEN; CD99 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPHOSPHAMIDE; CYTOKERATIN; DESMIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; KI 67 ANTIGEN; MESSENGER RNA; MOLECULAR MARKER; NEUROFILAMENT PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN P16; PROTEIN P53; PROTEIN S 100; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR FLI 1; VINCRISTINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CHROMOSOME TRANSLOCATION; DISEASE SEVERITY; DRUG METABOLISM; EWING SARCOMA; GENE EXPRESSION; GENE FUSION; GROUPS BY AGE; HUMAN; METASTASIS; MICROSATELLITE INSTABILITY; NERVE CELL DIFFERENTIATION; NEUROECTODERM TUMOR; NONHUMAN; ONTOGENY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 78349297177     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/856190     Document Type: Review

References (156)

1. Ewing J., Diffuse endothelioma of bone Proceedings of the New York Pathology Society 1921 21 17 24
2. Moll R., Gould V. E., Berndt R., Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation American Journal of Pathology 1987 127 2 288 304
3. Cavazzana A. O., Miser J. S., Jefferson J., Triche T. J., Experimental evidence for a neural origin of Ewing's sarcoma of bone American Journal of Pathology 1987 127 3 507 518
4. Lipinski M., Braham K., Philip I., Neuroectoderm-associated antigens on Ewing's sarcoma cell lines Cancer Research 1987 47 1 183 187
5. Lipinski M., Hirsch M.-R., Deagostini-Bazin H., Characterization of neural cell adhesion molecules (NCAM) expressed by ewing and neuroblastoma cell lines International Journal of Cancer 1987 40 1 81 86
6. Kawaguchi K., Koike M., Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm: the relationship to Ewing's sarcoma in bone and soft tissue American Journal of Clinical Pathology 1986 86 1 79 83
7. Llombart-Bosch A., Lacombe M. J., Contesso G., Peydro-Olaya A., Small round blue cell sarcoma of bone mimicking atypical Ewing's sarcoma with neuroectodermal features. An analysis of five cases with immunohistochemical and electron microscopic support Cancer 1987 60 7 1570 1582
8. Stout A. P., A tumor of the ulnar nerve Proceedings of the New York Pathology Society 1918 18 2 12
9. Angervall L., Enzinger F. M., Extraskeletal neoplasm resembling Ewing's sarcoma Cancer 1975 36 1 240 251
10. Soule E. H., Newton W. Jr., Moon T. E., Tefft M., Extraskeletal Ewing's sarcoma. A preliminary review of 26 cases encountered in the intergroup rhabdomyosarcoma study Cancer 1978 42 1 259 264
11. Nascimento A. G., Cooper K. L., Unni K. K., A clinicopathologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone American Journal of Surgical Pathology 1980 4 1 29 36
12. Askin F. B., Rosal J., Sibley R. K., Malignant small cell tumor of the thoracopulmonary region in childhood. A distinctive clinicopathologic entity of uncertain histogenesis Cancer 1979 43 6 2438 2451
13. Jaffe R., Santamaria M., Yunis E. J., The neuroectodermal tumor of bone American Journal of Surgical Pathology 1984 8 12 885 898
14. Schmidt D., Mackay B., Ayala A. G., Ewing's sarcoma with neuroblastoma-like features Ultrastructural Pathology 1982 3 2 143 151
15. Dehner L. P., Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus Archives of Pathology and Laboratory Medicine 1986 110 11 997 1005
16. Dehner L. P., Primitive neuroectodermal tumor and Ewing's sarcoma American Journal of Surgical Pathology 1993 17 1 1 13
17. Yunis E. J., Ewing's sarcoma and related small round cell neoplasms in children American Journal of Surgical Pathology 1986 10 54 62
18. Navarro S., Cavazzana A. O., Llombart-Bosch A., Triche T. J., Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma: an immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms Archives of Pathology and Laboratory Medicine 1994 118 6 608 615
19. Le Deley M. C., Delattre O., Schaefer K. L., Burchill S. A., Koehler G., Hogendoorn P. C., Lion T., Poremba C., Marandet J., Ballet S., Pierron G., Brownhill S. C., Nesslbck M., Ranft A., Dirksen U., Oberlin O., Lewis I. J., Craft A. W., Jrgens H., Kovar H., Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial Journal of Clinical Oncology 2010 28 12 1982 1988
20. Riggi N., Cironi L., Provero P., Suv M.-L., Kaloulis K., Garcia-Echeverria C., Hoffmann F., Trumpp A., Stamenkovic I., Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells Cancer Research 2005 65 24 11459 11468
21. Tirode F., Laud-Duval K., Prieur A., Delorme B., Charbord P., Delattre O., Mesenchymal stem cell features of ewing tumors Cancer Cell 2007 11 5 421 429
22. Ordez J. L., Osuna D., Herrero D., De lava E., Madoz-Grpide J., Advances in Ewing's sarcoma research: where are we now and what lies ahead? Cancer Research 2009 69 18 7140 7150
23. Folpe A. L., Goldblum J. R., Rubin B. P., Shehata B. M., Liu W., Dei Tos A. P., Weiss S. W., Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases American Journal of Surgical Pathology 2005 29 8 1025 1033
24. Llombart-Bosch A., Machado I., Navarro S., Bertoni F., Bacchini P., Alberghini M., Karzeladze A., Savelov N., Petrov S., Alvarado-Cabrero I., Mihaila D., Terrier P., Lopez-Guerrero J. A., Picci P., Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support Virchows Archiv 2009 455 5 397 411
25. Dickman P. S., Electron microscopy for diagnosis of tumors in children Perspectives in pediatric pathology 1987 9 171 213
26. Kissane J. M., Askin F. B., Foulkes M., Ewing's sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing's Sarcoma Study Human Pathology 1983 14 9 773 779
27. Schmidt D., Herrmann C., Jurgens H., Harms D., Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma: a report from the Kiel Pediatric Tumor Registry Cancer 1991 68 10 2251 2259
28. Pinto A., Grant L. H., Hayes F. A., Schell M. J., Parham D. M., Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone Cancer 1989 64 6 1266 1273
29. Ladanyi M., Heinemann F. S., Huvos A. G., Rao P. H., Chen Q., Jhanwar S. C., Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases Human Pathology 1990 21 12 1245 1251
30. Bridge J. A., Fidler M. E., Neff J. R., Degenhardt J., Wang M., Walker C., Dorfman H. D., Baker K. S., Seemayer T. A., Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift American Journal of Surgical Pathology 1999 23 2 159 165
31. Kanamori M., Antonescu C. R., Scott M., Bridge R.S. JR., Neff J. R., Spanier S. S., Scarborough M. T., Vergara G., Rosenthal H. G., Bridge J. A., Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in Adamantinoma Journal of Molecular Diagnostics 2001 3 1 16 21
32. Enzinger F. M., Weiss S. W., Soft Tissue Tumors 1983 1st St. Louis, Mo, USA Mosby
33. Cavazzana A. O., Ninfo V., Roberts J., Triche T. J., Peripheral neuroepithelioma: a light microscopic, immunocytochemical, and ultrastructural study Modern Pathology 1992 5 1 71 78
34. Katz R. L., Quezado M., Senderowicz A. M., Villalba L., Laskin W. B., Tsokos M., An intra-abdominal small round cell neoplasm with features of primitive neuroectodermal and desmoplastic round cell tumor and a EWS/FLI-1 fusion transcript Human Pathology 1997 28 4 502 509
35. Triche T. J., Askin F. B., Kissane J., Finegold M., Neuroblastoma, Ewing's sarcoma, and the differential diagnosis of small-, round-, blue-cell tumors Major Problems in Pathology: Pathology of Neoplasia in Children and Adolescents 1986 Philadelphia, Pa, USA WB Saunders 145 195
36. Williams S., Parham D. M., Jenkins J. J. III, Peripheral neuroepithelioma with ganglion cells: report of two cases and review of the literature Pediatric and Developmental Pathology 1999 2 1 42 49
37. Knezevich S. R., Hendson G., Mathers J. A., Carpenter B., Lopez-Terrada D., Brown K. L., Sorensen P. H. B., Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma Human Pathology 1998 29 3 289 294
38. Stevenson A. J., Chatten J., Bertoni F., CD99 (p30/32MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience Applied Immunohistochemistry 1994 2 2 231 240
39. Folpe A. L., Hill C. E., Parham D. M., O'Shea P. A., Weiss S. W., Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor American Journal of Surgical Pathology 2000 24 12 1657 1662
40. Parham D. M., Parham D. M., Ewing's sarcoma, peripheral neuroepithelioma, and related tumors Pediatric Neoplasia: Morphology and Biology 1996 New York, NY, USA Raven Press 65 85
41. Kovar H., Dworzak M., Strehl S., Schnell E., Ambros I. M., Ambros P. F., Gadner H., Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor Oncogene 1990 5 7 1067 1070
42. Cerisano V., Aalto Y., Perdichizzi S., Bernard G., Manara M. C., Benini S., Cenacchi G., Preda P., Lattanzi G., Nagy B., Knuutila S., Colombo M. P., Bernard A., Picci P., Scotlandi K., Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators Oncogene 2004 23 33 5664 5674
43. Schenkel A. R., Dufour E. M., Chew T. W., Sorg E., Muller W. A., The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response Cell Communication and Adhesion 2007 14 5 227 237
44. Rocchi A., Manara M. C., Sciandra M., Zambelli D., Nardi F., Nicoletti G., Garofalo C., Meschini S., Astolfi A., Colombo M. P., Lessnick S. L., Picci P., Scotlandi K., CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis The Journal of Clinical Investigation 2010 120 3 668 680
45. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., De Jong P., Rouleau G., Aurias A., Thomas G., Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 1992 359 6391 162 165
46. Sharrocks A. D., Brown A. L., Ling Y., Yates P. R., The ETS-domain transcription factor family International Journal of Biochemistry and Cell Biology 1997 29 12 1371 1387
47. Nilsson G., Wang M., Wejde J., Kreicbergs A., Larsson O., Detection of EWS/FLI-1 by immunostaining. An adjunctive tool in diagnosis of Ewing's sarcoma and primitive neuroectodermal tumour on cytological samples and paraffin-embedded archival material Sarcoma 1999 3 1 25 32
48. Llombart-Bosch A., Navarro S., Immunohistochemical detection of EWS and FLI-1 proteins in ewing sarcoma and primitive neuroectodermal tumors: comparative analysis with CD99 (MIC-2) expression Applied Immunohistochemistry and Molecular Morphology 2001 9 3 255 260
49. Smart E. J., Graf G. A., McNiven M. A., Sessa W. C., Engelman J. A., Scherer P. E., Okamoto T., Lisanti M. P., Caveolins, liquid-ordered domains, and signal transduction Molecular and Cellular Biology 1999 19 11 7289 7304
50. Williams T. M., Lisanti M. P., Caveolin-1 in oncogenic transformation, cancer, and metastasis American Journal of Physiology 2005 288 3 57-3 C494 C506
51. Tirado O. M., Mateo-Lozano S., Villar J., Dettin L. E., Llort A., Gallego S., Ban J., Kovar H., Notario V., Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells Cancer Research 2006 66 20 9937 9947
52. Dickman P. S., Triche T. J., Extraosseous Ewing's sarcoma versus primitive rhabdomyosarcoma: diagnostic criteria and clinical correlation Human Pathology 1986 17 9 881 893
53. Shimada H., Newton W. A. Jr., Soule E. H., Qualman S. J., Aoyama C., Maurer H. M., Pathologic features of extraosseous Ewing's sarcoma: a report from the intergroup rhabdomyosarcoma study Human Pathology 1988 19 4 442 453
54. Parham D. M., Hijazi Y., Steinberg S. M., Meyer W. H., Horowitz M., Tzen C.-Y., Wexler L. H., Tsokos M., Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior Human Pathology 1999 30 8 911 918
55. Parham D. M., Dias P., Kelly D. R., Rutledge J. C., Houghton P., Desmin positivity in primitive neuroectodermal tumors of childhood American Journal of Surgical Pathology 1992 16 5 483 492
56. Thorner P., Squire J., Chilton-MacNeill S., Marrano P., Bayani J., Malkin D., Greenberg M., Lorenzana A., Zielenska M., Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types American Journal of Pathology 1996 148 4 1125 1138
57. Sorensen P. H. B., Shimada H., Liu X. F., Lim J. F., Thomas G., Triche T. J., Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene Cancer Research 1995 55 6 1385 1392
58. Bou D. R., Parham D. M., Webber B., Crist W. M., Qualman S. J., Clinicopathologic study of ectomesenchymomas from intergroup rhabdomyosarcoma study groups III and IV Pediatric and Developmental Pathology 2000 3 3 290 300
59. Huntly B. J. P., Gilliland D. G., Cancer biology: summing up cancer stem cells Nature 2005 435 7046 1169 1170
60. Suv M.-L., Riggi N., Stehle J.-C., Baumer K., Tercier S., Joseph J.-M., Suv D., Clment V., Provero P., Cironi L., Osterheld M.-C., Guillou L., Stamenkovic I., Identification of cancer stem cells in Ewing's sarcoma Cancer Research 2009 69 5 1776 1781
61. Jiang X., Gwye Y., Russell D., Cao C., Douglas D., Hung L., Kovar H., Triche T. J., Lawlor E. R., CD133 expression in chemo-resistant Ewing sarcoma cells BMC Cancer 2010 10, article 116
62. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1981 The New England Journal of Medicine 1981 305 14 814 823
63. Spunt S. L., Skapek S. X., Coffin C. M., Pediatric nonrhabdomyosarcoma soft tissue sarcomas Oncologist 2008 13 6 668 678
64. De Alava E., Gerald W. L., Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family Journal of Clinical Oncology 2000 18 1 204 213
65. Ginsberg J. P., De Alava E., Ladanyi M., Wexler L. H., Kovar H., Paulussen M., Zoubek A., Dockhorn-Dworniczak B., Juergens H., Wunder J. S., Andrulis I. L., Malik R., Sorensen P. H. B., Womer R. B., Barr F. G., EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma Journal of Clinical Oncology 1999 17 6 1809 1814
66. Mertens F., Antonescu C. R., Hohenberger P., Ladanyi M., Modena P., D'Incalci M., Casali P. G., Aglietta M., Alvegrd T., Translocation-related sarcomas Seminars in Oncology 2009 36 4 312 323
67. Romeo S., Dei Tos A. P., Soft tissue tumors associated with EWSR1 translocation Virchows Archiv 2009 456 2 219 234
68. Ordez J. L., Osuna D., Garca-Domnguez D. J., Amaral A. T., Otero-Motta A. P., MacKintosh C., Sevillano M. V., Barbado M. V., Hernndez T., De Alava E., The clinical relevance of molecular genetics in soft tissue sarcomas Advances in Anatomic Pathology 2010 17 3 162 181
69. Zucman J., Melot T., Desmaze C., Ghysdael J., Plougastel B., Peter M., Zucker J. M., Triche T. J., Sheer D., Turc-Carel C., Ambros P., Combaret V., Lenoir G., Aurias A., Thomas G., Delattre O., Combinatorial generation of variable fusion proteins in the Ewing family of tumours The EMBO Journal 1993 12 12 4481 4487
70. Barr F. G., Womer R. B., Molecular diagnosis of Ewing family tumors too many fusions..? Journal of Molecular Diagnostics 2007 9 4 437 440
71. De Alava E., Kawai A., Healey J. H., Fligman I., Meyers P. A., Huvos A. G., Gerald W. L., Jhanwar S. C., Argani P., Antonescu C. R., Pardo-Mindan F. J., Ginsberg J., Womer R., Lawlor E. R., Wunder J., Andrulis I., Sorensen P. H. B., Barr F. G., Ladanyi M., EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma Journal of Clinical Oncology 1998 16 4 1248 1255
72. Zoubek A., Dockhorn-Dworniczak B., Delattre O., Christiansen H., Niggli F., Gatterer-Menz I., Smith T. L., Jrgens H., Gadner H., Kovar H., Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? Journal of Clinical Oncology 1996 14 4 1245 1251
73. De Alava E., Kawai A., Healey J. H., Fligman I., Meyers P. A., Huvos A. G., Gerald W. L., Jhanwar S. C., Argani P., Antonescu C. R., Pardo-Mindan F. J., Ginsberg J., Womer R., Lawlor E. R., Wunder J., Andrulis I., Sorensen P. H. B., Barr F. G., Ladanyi M., EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma Journal of Clinical Oncology 1998 16 4 1248 1255
74. Codrington R., Pannell R., Forster A., Drynan L. F., Daser A., Lobato N., Metzler M., Rabbitts T. H., The Ews-ERG fusion protein can initiate neoplasia from lineage-committed haematopoietic cells PLoS Biology 2005 3 8, article e242
75. Wang L., Bhargava R., Zheng T., Wexler L., Collins M. H., Roulston D., Ladanyi M., Undifferentiated small roud cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions Journal of Molecular Diagnostics 2007 9 4 498 509
76. Ordi J., De Alava E., Torn A., Mellado B., Pardo-Mindan J., Iglesias X., Cardesa A., Intraabdominal desmoplastic small round cell tumor with EWS/ERG fusion transcript American Journal of Surgical Pathology 1998 22 8 1026 1032
77. Shing D. C., McMullan D. J., Roberts P., Smith K., Chin S.-F., Nicholson J., Tillman R. M., Ramani P., Cullinane C., Coleman N., FUS/ERG gene fusions in Ewing's tumors Cancer Research 2003 63 15 4568 4576
78. Ng T. L., O'Sullivan M. J., Pallen C. J., Hayes M., Clarkson P. W., Winstanley M., Sorensen P. H. B., Nielsen T. O., Horsman D. E., Ewing sarcoma with novel translocation t(2;16) producing an in-flame fusion of FUS and FEV Journal of Molecular Diagnostics 2007 9 4 459 463
79. Armengol G., Tarkkanen M., Virolainen M., Forus A., Valle J., Bhling T., Asko-Seljavaara S., Blomqvist C., Elomaa I., Karaharju E., Kivioja A. H., Siimes M. A., Tukiainen E., Caballn M. R., Myklebost O., Knuutila S., Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization British Journal of Cancer 1997 75 10 1403 1409
80. Tarkkanen M., Kiuru-Kuhlefelt S., Blomqvist C., Armengol G., Bhling T., Ekfors T., Virolainen M., Lindholm P., Monge O., Picci P., Knuutila S., Elomaa I., Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors Cancer Genetics and Cytogenetics 1999 114 1 35 41
81. Nucci M. R., Weremowicz S., Neskey D. M., Sornberger K., Tallini G., Morton C. C., Quade B. J., Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors Genes Chromosomes and Cancer 2001 32 2 164 171
82. Savola S., Klami A., Tripathi A., Niini T., Serra M., Picci P., Kaski S., Zambelli D., Scotlandi K., Knuutila S., Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors BMC Cancer 2009 9, article 17
83. Ohali A., Avigad S., Zaizov R., Ophir R., Horn-Saban S., Cohen I. J., Meller I., Kollender Y., Issakov J., Yaniv I., Prediction of high risk Ewing's sarcoma by gene expression profiling Oncogene 2004 23 55 8997 9006
84. Schaefer K.-L., Eisenacher M., Braun Y., Brachwitz K., Wai D. H., Dirksen U., Lanvers-Kaminsky C., Juergens H., Herrero D., Stegmaier S., Koscielniak E., Eggert A., Nathrath M., Gosheger G., Schneider D. T., Bury C., Diallo-Danebrock R., Ottaviano L., Gabbert H. E., Poremba C., Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy European Journal of Cancer 2008 44 5 699 709
85. Smith R., Owen L. A., Trem D. J., Wong J. S., Whangbo J. S., Golub T. R., Lessnick S. L., Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma Cancer Cell 2006 9 5 405 416
86. Owen L. A., Lessnick S. L., Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma Cell Cycle 2006 5 18 2049 2053
87. Hancock J. D., Lessnick S. L., A transcriptional profiling meta-analysis reveals a core EWS-FLI gene expression signature Cell Cycle 2008 7 2 250 256
88. Lessnick S. L., Dei Tos A. P., Sorensen P. H. B., Dileo P., Baker L. H., Ferrari S., Hall K. S., Small Round Cell Sarcomas Seminars in Oncology 2009 36 4 338 346
89. Abudu A., Mangham D. C., Reynolds G. M., Pynsent P. B., Tillman R. M., Carter S. R., Grimer R. J., Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis British Journal of Cancer 1999 79 7-8 1185 1189
90. De Alava E., Antonescu C. R., Panizo A., Leung D., Meyers P. A., Huvos A. G., Pardo-Mindn F. J., Healey J. H., Ladanyi M., Prognostic impact of P53 status in Ewing sarcoma Cancer 2000 89 4 783 792 (Pubitemid 30658577)
91. Huang H.-Y., Illei P. B., Zhao Z., Mazumdar M., Huvos A. G., Healey J. H., Wexler L. H., Gorlick R., Meyers P., Ladanyi M., Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse Journal of Clinical Oncology 2005 23 3 548 558
92. Brownhill S. C., Taylor C., Burchill S. A., Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT British Journal of Cancer 2007 96 12 1914 1923
93. Lopez-Guerrero J.A., Machado I., Scotlandi K., Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors. International Journal of Cancer. In press
94. Alldinger I., Schaefer K. L., Goedde D., Ottaviano L., Dirksen U., Ranft A., Juergens H., Gabbert H. E., Knoefel W. T., Poremba C., Microsatellite instability in Ewing tumor is not associated with loss of mismatch repair protein expression Journal of Cancer Research and Clinical Oncology 2007 133 10 749 759
95. Gangwal K., Sankar S., Hollenhorst P. C., Kinsey M., Haroldsen S. C., Shah A. A., Boucher K. M., Watkins W. S., Jorde L. B., Graves B. J., Lessnick S. L., Microsatellites as EWS/FLI response elements in Ewing's sarcoma Proceedings of the National Academy of Sciences of the United States of America 2008 105 29 10149 10154
96. Gangwal K., Lessnicke S. L., Microsatellites are EWS/FLI response elements: genomic junk is EWS/FLI's treasure Cell Cycle 2008 7 20 3127 3132
97. Kinsey M., Smith R., Lessnick S. L., NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma Molecular Cancer Research 2006 4 11 851 859
98. Riggi N., Suv M.-L., Suv D., Cironi L., Provero P., Tercier S., Joseph J.-M., Stehle J.-C., Baumer K., Kindler V., Stamenkovic I., EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells Cancer Research 2008 68 7 2176 2185
99. Torchia E. C., Jaishankar S., Baker S. J., Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells Cancer Research 2003 63 13 3464 3468
100. Riggi N., Suv M.-L., De Vito C., Provero P., Stehle J.-C., Baumer K., Cironi L., Janiszewska M., Petricevic T., Suv D., Tercier S., Joseph J.-M., Guillou L., Stamenkovic I., EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells Genes and Development 2010 24 9 916 932
101. Hu-Lieskovan S., Zhang J., Wu L., EWS-FLI1 fusin protein up-regulates critical genes in neurtal crest development and is responsible for the observed phenotype of Ewing's family of tumors Cancer Research 2005 65 11 4633 4644
102. Baliko F., Bright T., Poon R., Cohen B., Egan S. E., Alman B. A., Inhibition of notch signaling induces neural differentiation in Ewing sarcoma American Journal of Pathology 2007 170 5 1686 1694
103. Shanfeld R. L., Edelman J., Willis J. E., Tuason L., Goldblum J. R., Immunohistochemical analysis of neural markers in peripheral primitive neuroectodermal tumors (pPNET) without light microscopic evidence of neural differentiation Applied Immunohistochemistry and Molecular Morphology 1997 5 2 78 86
104. Gascoyne D. M., Dunne J., Behjati S., Sebire N. J., Anderson J., Latchman D. S., EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A Oncogene 2010 29 21 3134 3145
105. van Doorninck J. A., Ji L., Schaub B., Shimada H., Wing M. R., Krailo M. D., Lessnick S. L., Marina N., Triche T. J., Sposto R., Womer R. B., Lawlor E. R., Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the children's Oncology Group Journal of Clinical Oncology 2010 28 12 1989 1994
106. Grier H. E., Krailo M. D., Tarbell N. J., Link M. P., Fryer C. J. H., Pritchard D. J., Gebhardt M. C., Dickman P. S., Perlman E. J., Meyers P. A., Donaldson S. S., Moore S., Rausen A. R., Vietti T. J., Miser J. S., Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone The New England Journal of Medicine 2003 348 8 694 701
107. Craft A. W., Cotterill S. J., Bullimore J. A., Pearson D., Long-term results from the first UKCCSG Ewing's tumour study (ET-1) European Journal of Cancer Part A 1997 33 7 1061 1069
108. Cotterill S. J., Ahrens S., Paulussen M., Jurgens H. F., Voute P. A., Gadner H., Craft A. W., Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group Journal of Clinical Oncology 2000 18 17 3108 3114
109. Tageja N., Prognostic indicators for ewing's sarcoma The Lancet 2010 376 9737 232
110. Leavey P. J., Mascarenhas L., Marina N., Chen Z., Krailo M., Miser J., Brown K., Tarbell N., Bernstein M. L., Granowetter L., Gebhardt M., Grier H. E., Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: a report from the children's oncology group Pediatric Blood and Cancer 2008 51 3 334 338
111. Ladenstein R., Ptschger U., Le Deley M. C., Whelan J., Paulussen M., Oberlin O., van den Berg H., Dirksen U., Hjorth L., Michon J., Lewis I., Craft A., Jrgens H., Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial Journal of Clinical Oncology 2010 28 20 3284 3291
112. Paulussen M., Ahrens S., Burdach S., Craft A., Dockhorn-Dworniczak B., Dunst J., Frhlich B., Winkelmann W., Zoubek A., Jrgens H., Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies Annals of Oncology 1998 9 3 275 281
113. Paulussen M., Ahrens S., Craft A. W., Ewing tumors with primary lungmetastases: survival analysis of 114 (European Intergroup) Ewing Sarcoma Studies patients Journal of Clinical Oncology 1998 16 3044 3052
114. Rodrguez-Galindo C., Liu T., Krasin M. J., Wu J., Billups C. A., Daw N. C., Spunt S. L., Rao B. N., Santana V. M., Navid F., Analysis of prognostic factors in Ewing sarcoma family of tumors Cancer 2007 110 2 375 384
115. Jurgens H., Exner U., Gardner H., Multidisciplinary treatment of primary Ewings sarcoma of bone Cancer 1988 7 208 213
116. Miser J. S., Kraito M. D., Tarbell N. J., Treatment of metastatic Ewings sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide: a childrens Cancer group and Pediatric Oncology Group study Journal of Clinical Oncology 2004 22 2873 2876
117. Rodrguez-Galindo C., Navid F., Liu T., Billups C. A., Rao B. N., Krasin M. J., Prognostic factors for local and distant control in Ewing sarcoma family of tumors Annals of Oncology 2008 19 4 814 820
118. Rodriguez-Galindo C., Spunt S. L., Pappo A. S., Review treatment of ewing sarcoma family of tumors: current status and outlook for the future Medical Pediatric Oncology 2003 40 276 287
119. Paulussen M., Ahrens S., Dunst J., Winkelmann W., Exner G. U., Kotz R., Amann G., Dockhorn-Dworniczak B., Harms D., Mller-Weihrich S., Welte K., Kornhuber B., Janka-Schaub G., Gbel U., Treuner J., Vote P. A., Zoubek A., Gadner H., Jrgens H., Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma study CESS 86 Journal of Clinical Oncology 2001 19 6 1818 1829
120. Derek Jenkin R., Al-Fawaz I., Al-Shabanah M., Allam A., Ayas M., Khafaga Y., Memon M., Rifai S., Schultz H., Younge D., Localised Ewing sarcoma/PNET of boneprognostic factors and international data comparison Medical and Pediatric Oncology 2002 39 6 586 593
121. Bacci G., Ferrari S., Longhi A., Rimondini S., Versari M., Zanone A., Forni C., Prognostic significance of serum LDH in Ewing's sarcoma of bone Oncology Reports 1999 6 4 807 811
122. Hattinger C. M., Potsguer U., Tarkannen M., Prognostic impact of chromosomal aberrations in Ewing tumors British Journal of Cancer 2002 86 1763 1769
123. Wei G., Antonescu C. R., De Alava E., Leung D., Huvos A. G., Meyers P. A., Healey J. H., Ladanyi M., Prognostic impact of INK4A deletion in Ewing sarcoma Cancer 2000 89 4 793 799 (Pubitemid 30658578)
124. Gupta A. A., Pappo A., Saunders N., Clinical outcome of children and adults with localized Ewing sarcoma, impact of chemotherapy dose and timing of local therapy Cancer 2010 116 3189 3194
125. Ferrari S., Bertoni F., Palmerini E., Errani C., Bacchini P., Pignotti E., Mercuri M., Longhi A., Cesari M., Picci P., Predictive factors of histologic response to primary chemotherapy in patients with ewing sarcoma Journal of Pediatric Hematology/Oncology 2007 29 6 364 368
126. Bacci G., Ferrari S., Bertoni F., Rimondini S., Longhi A., Bacchini P., Forni C., Manfrini M., Donati D., Picci P., Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli Journal of Clinical Oncology 2000 18 1 4 11
127. Verrill M. W., Judson I. R., Harmer C. L., Fisher C., Thomas J. M., Wiltshaw E., Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? Journal of Clinical Oncology 1997 15 7 2611 2621
128. Fizazi K., Dohollou N., Blay J.-Y., Gurin S., Le Cesne A., Andr F., Pouillart P., Tursz T., Bui N. B., Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients Journal of Clinical Oncology 1998 16 12 3736 3743
129. Lee J., Hoang B. H., Ziogas A., Zell J. A., Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry Cancer 2010 116 8 1964 1973
130. Hayes F. A., Thompson E. I., Meyer W. H., Kun L., Parham D., Rao B., Kumar M., Hancock M., Parvey L., Magill L., Hustu H. O., Therapy for localized Ewing's sarcoma of bone Journal of Clinical Oncology 1989 7 2 208 213
131. Marina N. M., Pappo A. S., Parham D. M., Cain A. M., Rao B. N., Poquette C. A., Pratt C. B., Greenwald C., Meyer W. H., Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude children's research hospital Journal of Clinical Oncology 1999 17 1 180 190
132. Paulussen M., Craft A. W., Lewis I., Hackshaw A., Douglas C., Dunst J., Schuck A., Winkelmann W., Khler G., Poremba C., Zoubek A., Ladenstein R., Van Den Berg H., Hunold A., Cassoni A., Spooner D., Grimer R., Whelan J., McTiernan A., Jrgens H., Results of the EICESS-92 study: two randomized trials of Ewing's sarcoma treatmentcyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients Journal of Clinical Oncology 2008 26 27 4385 4393
133. DuBois S. G., Grier H. E., Chemotherapy: the role of ifosfamide and etoposide in Ewing sarcoma Nature Reviews Clinical Oncology 2009 6 5 251 253
134. Evans R., Nesbit M., Askin F., Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones International Journal of Radiation Oncology Biology Physics 1985 11 1 129 136
135. Burgert E. O. Jr., Nesbit M. E., Garnsey L. A., Gehan E. A., Herrmann J., Vietti T. J., Cangir A., Tefft M., Evans R., Thomas P., Askin F. B., Kissane J. M., Pritchard D. J., Neff J., Makley J. T., Gilula L., Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II Journal of Clinical Oncology 1990 8 9 1514 1524
136. Craft A., Cotterill S., Malcolm A., Spooner D., Grimer R., Souhami R., Imeson J., Lewis I., Ifosfamide-containing chemotherapy in Ewing's sarcoma: the second United Kingdom children's Cancer Study Group and the Medical Research
137. Grier H., Krailo M., Link M., Improved outcome in non metastatic Ewings Sarcoma (ES) and PPNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), adryamicin (Ad), cyclophosphamide (C), and actinomycin (A): A Childrens Cancer group (CCG) and Pediatrin Oncology Group (POG) report Procceedings Annual Meeting American Society Clinical Oncology 1994 13. abstract no. 421
138. Luksch R., Sampietro G., Collini P., Boracchi P., Massimino M., Lombardi F., Gandola L., Giardini R., Fossati-Bellani F., Migliorini L., Pilotti S., Scopsi L., Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children Tumori 1999 85 2 101 107
139. Granowetter L., Womer R., Devidas M., Krailo M., Wang C., Bernstein M., Marina N., Leavey P., Gebhardt M., Healey J., Shamberger R. C., Goorin A., Miser J., Meyer J., Arndt C. A.S., Sailer S., Marcus K., Perlman E., Dickman P., Grier H. E., Dose-intensified compared with standard chemotherapy for nonmetastatic ewing sarcoma family of tumors: a children's oncology group study Journal of Clinical Oncology 2009 27 15 2536 2541
140. Dickman P. S., Askin F. B., Miser J., Pathology and prognosis in osseous Ewing's sarcoma-primitive neuroectodermal tumor (ES/PNET): preliminary data analysis from CCG 7881/POG 8850 Modern Pathology 1999 12 2
141. Bacci G., Forni C., Longhi A., Ferrari S., Donati D., De Paolis M., Barbieri E., Pignotti E., Rosito P., Versari M., Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992 European Journal of Cancer 2004 40 1 73 83
142. Bacci G., Longhi A., Ferrari S., Mercuri M., Versari M., Bertoni F., Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998 Acta Oncologica 2006 45 4 469 475 (Pubitemid 43884616)
143. Marec-Brard P., Chotel F., Claude L., Tumeurs PNET/Ewing: prise en charge actuelle et perspectives Bulletin du Cancer 2010 97 6 707 713
144. Balamuth N. J., Womer R. B., Ewing's sarcoma The Lancet Oncology 2010 11 2 184 192
145. Chen C.-S., Lin J. T., Goss K. A., He Y.-A., Halpert J. R., Waxman D. J., Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics Molecular Pharmacology 2004 65 5 1278 1285
146. Scripture C. D., Sparreboom A., Figg W. D., Modulation of cytochrome P450 activity: implications for cancer therapy The Lancet Oncology 2005 6 10 780 789
147. Fujita K.-I., Cytochrome P450 and anticancer drugs Current Drug Metabolism 2006 7 1 23 37
148. Furlanut M., Franceschi L., Phramacology of Ifosfamide Oncology 2003 65 supplement 2 2 6
149. Scotlandi K., Remondini D., Castellani G., Manara M. C., Nardi F., Cantiani L., Francesconi M., Mercuri M., Caccuri A. M., Serra M., Knuutila S., Picci P., Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome Journal of Clinical Oncology 2009 27 13 2209 2216
150. Townsend D. M., Tew K.D., The role of gluthatione-S-transferasse in anticancer drug resistance Oncogene 2003 22 7369 7375
151. Salzer-Kuntschik M., Delling G., Beron G., Morphologicla grades of regression in osteosarcoma after polychemotherapy COSS 80 Journal of Cancer Research Clinical Oncology 1983 106 supplement 1 21 24
152. Womer R. B., West D. C., Krailo M. D., Randomized comparison of every-two-week v. every-three-week chemotherapy in Ewing sarcoma family of tumors (ESFT) Journal of Clinical Oncology 2008 26 supplement 15. abstract no. 10504
153. Dirksen U., Jrgens H., Approaching Ewing sarcoma Future Oncology 2010 6 7 1155 1162
154. Ricci G., De Maria F., Antonini G., -7,nitro-2,1,3 benzoxadiazole derivatives a new class 0f suicide inhibitors for gluthatione S-transferases. Mechanism of action of potential anticancer drugs The Journal of Biological Chemistry 2005 280 26397 26405
155. Toomey E. C., Schiffman J. D., Lessnick S. L., Recent advances in the molecular pathogenesis of Ewing's sarcoma Oncogene 2010 29 32 4504 4516
156. Maire G., Brown C. W., Bayani J., Pereira C., Gravel D. H., Bell J. C., Zielenska M., Squire J. A., Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review Cancer Genetics and Cytogenetics 2008 181 2 81 92